Royal College of Nursing Ends Teva UK Partnership

The Royal College of Nursing (RCN), a prominent trade union representing nurses in the United Kingdom, has officially severed its commercial partnership with Teva UK, an Israeli pharmaceutical company. This decision was announced on October 2, 2026, and signifies a significant move by the RCN to distance itself from the drug manufacturer. The RCN has also withdrawn Teva UK's sponsorship for an upcoming event focused on migraine and headaches, which was scheduled to be held at the union's headquarters in London.

The primary reasons cited by the RCN for terminating the partnership revolve around Teva UK's perceived links to Israel's military and its history of corporate misconduct. While specific details regarding the nature of the military connections were not elaborated upon in the initial reports, the union's stance suggests a broader concern about the company's entanglement with the Israeli state's defense apparatus. Furthermore, the RCN's reference to a "track record of corporate misconduct" implies a pattern of behavior by Teva that the nursing union deems unacceptable for its commercial partners.

Teva Pharmaceutical Industries Ltd., the parent company of Teva UK, is a global leader in the production of generic and specialty medicines. Founded in Israel in 1901, the company has grown into one of the world's largest pharmaceutical manufacturers, with a significant presence in numerous countries. Teva's product portfolio includes a wide range of medications, from treatments for chronic conditions to innovative specialty drugs. However, the company has faced scrutiny and legal challenges in the past related to its business practices, including allegations concerning the marketing of opioid painkillers and anti-competitive behavior.

The RCN's decision to cut ties with Teva UK is likely to be viewed within the context of ongoing international discussions and activism related to the Israeli-Palestinian conflict. Trade unions and professional organizations globally have increasingly been urged to examine their relationships with companies operating in or closely associated with Israel. By ending this partnership, the RCN is aligning itself with a growing movement among some civil society groups to exert pressure on corporations and governments through economic and social means. The union's action underscores a commitment to ethical considerations in its commercial dealings, prioritizing its values over potential financial benefits derived from such partnerships.